Safety and Clinical Efficacy of PD-1 on Advanced Primary Hepatocellular Carcinoma

Safety and Clinical Efficacy of PD-1 on Advanced Primary Hepatocellular Carcinoma

Objective To observe the short-term clinical effect and total survival of advanced hepatocellular carcinoma patients treated with PD-1. Methods We retrospectively analyzed the clinical data of 48 patients with advanced hepatocellular carcinoma treated with PD-1 monoclonal antibody (observation group...

Full description

Bibliographic Details
Main Authors: WANG Yixin, HU Zongtao, ZHANG Yongkang, ZENG Ping, WANG Hongzhi
Format: Article
Language:zho
Published: Magazine House of Cancer Research on Prevention and Treatment 2020-04-01
Series:Zhongliu Fangzhi Yanjiu
Subjects:
hepatocellular carcinoma
immunotherapy
targeted therapy
pd-1
Online Access:http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1112.htm

Internet

http://html.rhhz.net/ZLFZYJ/html/8578.2020.19.1112.htm

Similar Items